Byron Hewett appointed as new SomaLogic CEO
December 3, 2013
The Board of Directors of SomaLogic Inc. (a privately held biotechnology company) announced today that Byron Hewett has been appointed as Chief Executive Officer (CEO), effective Dec 2, 2013. SomaLogic was founded in 2000 by its original CEO, Larry Gold, who will continue as Chairman of the Board. Dr. Gold will also continue to work [...]
Molecular Devices Announces Next-Generation SpectraMax MiniMax 300 Imaging Cytometer
December 3, 2013
Sunnyvale, CA – Molecular Devices®, the market leader in microplate reader technology for over 25 years, has announced today the next-generation SpectraMax® MiniMax™ 300 Imaging Cytometer. This MiniMax 300 imaging cytometer enables both cellular visualization and first-of-its-kind stain free cell-based analysis on the field-upgradable SpectraMax® i3 Multi-Mode Microplate Reader. Brightfield and fluorescence based green and [...]
December 3, 2013
Manassas, VA – ATCC, the premier global biological materials resource and standards organization, and Evercyte GmbH, a proven developer of immortalized human cells, have entered into a strategic partnership to develop and distribute immortalized cell lines that retain key performance characteristics of primary cells. Immortalized primary cell lines enable scientists to have a sufficient supply [...]
December 3, 2013
OXFORD, England -- Zyoxel, the world’s leading expert for advanced in vitro 3D liver models for drug discovery and drug testing, has announced preliminary results from a testing by Sanofi on Zyoxel’s LiverChip™ platform for drug metabolism and pharmacokinetic (DMPK) studies. Sanofi employed a variety of morphological, genetic and functional analyses to fully characterise the [...]
December 2, 2013
Maryville, TN -- Molecular Pathology Laboratory Network, Inc. (MPLN) announced today that it has acquired the Illumina MiSeqDx™, currently the only next generation sequencing system approved by the US Food and Drug Administration (FDA). MPLN will be the first laboratory in the country to own the FDA approved version of this revolutionary technology, and will [...]
TexturePro CT Software Now 21 CFR Compliant
December 2, 2013
Middleboro, MA - Texture Pro CT software from Brookfield is now 21CFR Part 11 compliant. Related features include controlled user access to specific test methods and data security for safe and permanent record keeping. This version is ideal for use by regulated industries, such as pharmaceuticals, nutritional supplements, foods, and personal care products. TexturePro CT [...]
Multiplicom expands its range of MASTR kits
December 2, 2013
Niel – Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing (MPS), today announces that it is launching a CE/IVD labeled MID kit for Illumina® MiSeq® together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity [...]
Core Informatics opens UK office, adds European industry veteran to leadership team
December 2, 2013
Branford, CT and London, England –— Core Informatics, a leading provider of data management solutions to clients engaged in scientific research, announced the establishment of Core Informatics UK Limited, the rapidly growing company’s first international subsidiary. Based in London, the unit will help provide direct support to Core Informatics’ rapidly growing group of European clients [...]
BioNJ Renews Strategic Laboratory Supply Purchasing Alliance with Fisher Scientific
December 2, 2013
TRENTON, N.J. -- BioNJ, the trade association for New Jersey’s life science industry, today announced it has renewed its 16-year Primary Supplier Agreement with Fisher Scientific, part of Waltham-based Thermo Fisher Scientific Inc. This agreement enables BioNJ Members to achieve significant savings on laboratory supplies and a variety of other services. “Our Members have already [...]
Ventria Bioscience Appoints Margaret Glick, Ph.D., CPA as Vice President of Finance
December 2, 2013
FORT COLLINS, Colo. -- Ventria Bioscience today announced that Margaret B. Glick, Ph.D., CPA has been appointed as the company’s new vice president of finance. Dr. Glick will oversee all financial and related administrative functions for the company. “Maggie comes to Ventria Bioscience with expertise in private and public corporate finance as well as organizational [...]

